Cheshire, UK -- (MARKET WIRE) -- October 16, 2006 --
Protherics PLC
BLOCK LISTING APPLICATION
16 October 2006: Protherics PLC ("Protherics"), the international
biopharmaceutical company focused on critical care and cancer, gives notice that
it has today made an application to the London Stock Exchange plc and the UK
Listing Authority for the additional listing of 68,200 Ordinary Shares of 2p
each (the " New Shares") arising upon conversion of 6% Convertible Unsecured
Loan Notes 2010 (the "Loan Notes"). The New Shares will be in addition to the
Company's original Block Listing of 17,092,476 Ordinary Shares, which were
admitted to the Official List on 8 February 2005. The balance of Ordinary
Shares remaining under the Block Listing for the Loan Notes is 9,212,060
Ordinary Shares.
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0) 1928 518010
Financial Dynamics - press enquiries
Ben Atwell, David Yates +44 (0) 20 7831 3113
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange